Apimeds Pharmaceuticals US (APUS) Plans to Raise $20 Million in March 10th IPO
Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at a price of $4.00-$5.00 per share. Apimeds Pharmaceuticals US has a market-cap of $57.1 million. D. Boral Capital (ex-EF Hutton) acted as the underwriter […]
Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at a price of $4.00-$5.00 per share. Apimeds Pharmaceuticals US has a market-cap of $57.1 million. D. Boral Capital (ex-EF Hutton) acted as the underwriter […]
